On April 7, 2026, the CME Group announced the launch of futures contracts for SUI and AVAX coming this May. The market reaction was immediate. SUI climbed nearly 10%<\/strong> over 24 hours to trade around $0.95<\/strong>, driven by this institutional announcement and the geopolitical easing linked to the US-Iran ceasefire. Two distinct catalysts within 24 hours are enough to put SUI back in the spotlight after several weeks of consolidation in a pressured altcoin market.<\/p>\n\n\n\n The CME integration is not merely a symbolic validation. CME will cash-settle all contracts in US dollars using daily reference rates from CF Benchmarks, the same index provider behind its Bitcoin<\/a> and Ether futures. CF Benchmarks aggregates AVAX and SUI prices from several major platforms and registers these rates under UK rules, making them suitable for institutional products. This introduction expands the CME’s portfolio of regulated cryptocurrencies, which now includes futures on Bitcoin, Ethereum, XRP, Cardano<\/a>, Chainlink, and Stellar.<\/p>\n\n\n\n For institutional investors, this type of integration is a game-changer: it opens access to SUI through regulated instruments without requiring direct custody of the token<\/a>. This is exactly what SUI has been missing to attract significant institutional capital until now. Those looking to buy SUI through regulated channels now have a new, tailored tool at their disposal.<\/p>\n\n\n\n